2 April 2025 Vida Ventures Taps Industry Heavyweights from JP Morgan and MPM BioImpact to Further Power Leadership Team read more
24 February 2025 Halda Therapeutics Announces First Patient Dosed in Phase 1/2 Clinical Trial Evaluating HLD-0915 in Metastatic Castration-Resistant Prostate Cancer read more
30 January 2025 Tectonic Therapeutic Announces Positive Interim Data from Phase 1b Trial for TX45 in Patients with Group 2 Pulmonary Hypertension in HFpEF read more
13 January 2025 Lilly to Acquire Scorpion Therapeutics’ Mutant-Selective PI3Kα Inhibitor Program read more
8 January 2025 LB Pharmaceuticals Announces Positive Topline Results from Phase 2 Trial of LB-102 in Schizophrenia read more
